جست‌وجوی استاد و پژوهشگر

Munmun Chattopadhyayمشاهده پروفایل

دانشیار

• Diabetic Complications
• Neuropathy
• Gastrointestinal Disorders
• +۱۱ مورد دیگر

Munmun Chattopadhyay, M.Sc, Ph.D., is an Associate Professor in the Department of Molecular and Translational Medicine at Texas Tech University Health Sciences Center El Paso, where she also chairs the Institutional Animal Care and Use Committee. She earned her MS in Zoology and Ph.D. in Neurosciences from Jiwaji University, Gwalior, India, and completed postdoctoral work at the National Institute of Immunology (New Delhi) and the University of Pittsburgh (Department of Neurology). Her academic career includes junior faculty roles at the University of Michigan (2010) before joining TTUHSC El Paso in 2014. Research Focus: Inflammatory mediators in diabetic complications, epigenetic modulators in neuropathy/cardiac dysfunction/gastroparesis, natural compounds, and exercise interventions. Major Themes: 15 recent articles highlight work on diabetic neuropathy , HMGB1 signaling , epigenetic therapies , 3D bioprinting , neuroinflammation , and novel pain targets (e.g., σ(2)R/TMEM97, Ephrin-B2). Scientific Awards: Faculty Service Award (2020), TTUHSC El Paso Women Worth Watching in STEM (2022) Nominated for 3D Printing Industry Awards (2021) Dr. Chattopadhyay serves as Associate Editor and Grant Review Panelist (NIH, ADA, DoD, NSF, NIHR) and has published >43 articles and 2 book chapters, including work on stem cell delivery systems , space biology , and bioinformatics applications in translational research.

Pedram Razaviمشاهده پروفایل

استادیار بالینی

• Breast Cancer Genomics
• Precision Oncology
• Liquid Biopsy
• +۳ مورد دیگر

Pedram Razavi serves as a Clinical Assistant Professor within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSKCC), where he holds appointments in the Breast Medicine Service and Solid Tumor Oncology Division. His clinical and research activities focus exclusively on advancing precision oncology for breast cancer patients through genomic and computational approaches. Dr. Razavi's research program centers on decoding the genomic architecture of metastatic breast cancer to develop predictive biomarkers and optimize therapeutic strategies. His work spans three critical domains: (1) liquid biopsy development for real-time ctDNA monitoring during CDK4/6 inhibitor therapy, (2) machine learning integration of multimodal data to predict real-world progression-free survival, and (3) mechanistic studies of mutational drivers like APOBEC3 and ERBB2 in therapy resistance. Recent investigations reveal how double PIK3CA mutations in cis configuration enhance oncogenicity while increasing PI3Kα inhibitor sensitivity, and how ERBB2 activating mutations enable trastuzumab deruxtecan efficacy in HER2-non-amplified disease. Analyzing his 184 publications (including 18 in 2025), a clear trajectory emerges toward clinically actionable genomic insights. Over 70% of his recent work appears in high-impact journals like Journal of Clinical Oncology (42 publications) and Cancer Research (26), with meeting abstracts dominating his 2025 output reflecting active clinical trial engagement. His research consistently bridges basic mechanisms (e.g., APOBEC3 mutagenesis driving resistance) with immediate clinical applications (e.g., ctDNA dynamics predicting treatment response). Dr. Razavi maintains an extensive collaborative network centered at MSKCC, with Sarat Chandarlapaty (79 co-publications), Jorge Reis-Filho (67), and Michael Berger (45) representing his core team. He actively participates in international initiatives like the Buenos Aires Breast Cancer Symposium, demonstrating global leadership in translating genomic discoveries into clinical practice for metastatic breast cancer.

Dan Berlauمشاهده پروفایل

استاد

• Neuroscience
• Pharmacology
• Cognitive Impairment
• +۴ مورد دیگر

Dan Berlau is a Professor at Regis University's Rueckert-Hartman College for Health Professions, specializing in pharmacy education and neuroscience research. Since 2011, he has taught physiology, pathophysiology, and pharmacology to pharmacy students, focusing on brain and central nervous system diseases while emphasizing active learning pedagogy. Research Interests: Neurodegenerative diseases, cannabis therapeutics, ADHD, statin mechanisms, and neuromuscular disorders Teaching: Prioritizes student engagement and has mentored students in publishing peer-reviewed articles His publications span topics including Duchenne muscular dystrophy therapies, opioid substitution with cannabis, and dementia risk factors. While not explicitly mentioning scientific awards, his research consistently involves student collaboration. Dr. Berlau's work with the 90+ Study highlights his focus on aging-related cognitive decline, examining amyloid pathology, cardiovascular risk factors, and noradrenergic mechanisms in memory consolidation through animal models.

Stephen J. Eylesمشاهده پروفایل

استاد

• Mass Spectrometry
• Protein Folding
• Hydrogen-Deuterium Exchange
• +۲ مورد دیگر

Stephen J. Eyles is Extension Professor and Director of the Mass Spectrometry Center at UMass Amherst. His research applies hydrogen/deuterium exchange mass spectrometry to study protein dynamics and folding, with emphasis on membrane protein complexes and biomolecular interactions. As center director, he develops analytical methods for campus researchers. Recent investigations characterize allosteric mechanisms in GPCR signaling, ER chaperone functions, and ubiquitin-proteasome regulation using advanced MS techniques.

• Molecular Therapy
• Genodermatoses
• Epidermolysis Bullosa
• +۴ مورد دیگر

Roland Zauner is a researcher affiliated with the Department of Dermatology and Allergology, focusing on molecular therapy for genodermatoses. His work primarily addresses rare skin disorders like epidermolysis bullosa and associated malignancies, employing approaches such as drug repurposing and microRNA analysis. Active in Pharmacology, Toxicology, and Pharmaceutical Science Research spans Epidermolysis Bullosa Dystrophica , Squamous Cell Carcinoma , and microRNA profiling Recent work includes drug repurposing for chronic wounds and biomarker discovery in rare malignancies His publications highlight expertise in protein modeling, yeast two-hybrid screening, and collagen type 7 modulation. Current projects involve exploring statins and diacerein for treating aggressive cutaneous tumors in recessive-dystrophic epidermolysis bullosa (RDEB) patients.

Anja Meissnerمشاهده پروفایل

استاد

• Vascular Physiology
• Cardiovascular Disease
• Neurovascular Biology
• +۶ مورد دیگر

Prof. Dr. Anja Meissner is a leading physiologist at the University of Augsburg's Medical School, specializing in vascular biology with affiliations to Lund University and DZNE Bonn. Her research focuses on Sphingosine-1-phosphate (S1P) signaling in cardiovascular diseases, hypertension, and neurovascular interactions. University of Augsburg, Medical School Lund University collaborations DZNE Bonn partnerships Research Highlights: Investigates immune system roles in hypertension, heart failure's target organ effects, S1P pathway in stroke, cardiovascular risk factors' impact on brain function, and environmental influences on vascular health. Key methods include non-invasive imaging , flow cytometry , and in vitro/ex vivo models . Publication Trends: Recent work emphasizes microfluidic neurovascular models , glymphatic system dysfunction , and sex-specific cardiovascular responses . Collaborations span neurology, cardiology, and environmental science institutions. Awards & Grants: DFG Project Funding (2025-2028) Hjärnfonden Grant (2024-2025) Albert Påhlsson Foundation (2022-2025) Swedish Research Council (2023-2026) Educational Impact: Mentored 15+ PhD students including Lotte Vanherle and Frank Matthes. Leads international research teams with scholars from Sweden, Belgium, Italy, and Canada. Current grants focus on CFTR therapeutics and sex-specific hypertension consequences .

• Dementia Research
• Geriatric Neurology
• Registry-Based Epidemiology
• +۵ مورد دیگر

Sara Garcia Ptacek is an Assistant Professor and Docent at Karolinska Institutet, affiliated with the Department of Neurobiology, Care Sciences and Society and the Maria Eriksdotter research group. She maintains a dual role as a neurologist at the Cognitive Clinic, Karolinska University Hospital in Solna, with 50% research activity. Her research spans dementia epidemiology , geriatric neurology , and registry-based studies . Key interests include medication repurposing to slow cognitive decline, the impact of COVID-19 on dementia care, and dementia with Lewy bodies through collaboration with the European Dementia with Lewy bodies consortium. She utilizes the Swedish Dementia Registry (SveDem) with over 100,000 patients for longitudinal cognitive assessment studies. Her recent publications demonstrate strong focus on health disparities in dementia care , comorbidity effects on cognitive trajectories , and methodological innovations combining traditional cohort studies with machine learning. Her work frequently appears in high-impact journals including Nature Communications , Neurology , and JAMA Network Open . Scientific recognition includes: Docent in Neurosciences at Karolinska Institutet (2023) Fellow of the European Board of Neurology (FEBN) (2019) Prize for Clinical Thesis from Spanish National Royal Academy of Medicine (2017) Excellence prize for PhD thesis from Universidad Complutense de Madrid (2015) Current research initiatives include "Innovative ways to fight Alzheimer's disease" (funded by Leif Lundblad Family donation, 2023-2026) and "Causal inference using Dynamic Bayesian Networks" (Loo and Hans Osterman Foundation, 2022-2023). Her work bridges clinical neurology with population health research, focusing on improving dementia diagnosis, care quality, and treatment outcomes through registry science. She contributes to major international collaborations including the European Dementia with Lewy bodies (E-DLB) consortium and maintains active research on pandemic impacts on dementia care and health disparities in dementia diagnostics.

Giske Ursinمشاهده پروفایل

استاد

• Cancer epidemiology
• Nutritional epidemiology
• Genetics and cancer

Giske Ursin is a Professor at the Department of Nutritional Sciences, Institute of Basic Medical Sciences, University of Oslo, and currently serves as Division Director at the Norwegian Institute of Public Health. Her research focuses on cancer epidemiology , nutritional epidemiology , and genetics , with a particular emphasis on breast and prostate cancer risk factors, hormonal influences, and population-level health trends. She has led large-scale studies on the impact of menopausal hormone therapy, BMI trajectories, and socioeconomic factors on cancer incidence and mortality. Her work often leverages Norwegian registry data, including collaborations with the Norwegian Cancer Registry and international consortia. Recent publications highlight her expertise in Longitudinal cancer survival analysis Pandemic-related cancer incidence shifts Hormonal and pharmacological interventions in cancer risk Epidemiological modeling of immigrant populations She has contributed to studies on digital health interventions for cancer survivors and pharmacovigilance of prescription drugs. Her research bridges clinical data with public health policy, influencing cancer prevention strategies and screening programs.

John Kellyمشاهده پروفایل

استاد

• Molecular Parasitology
• Drug Resistance
• Chagas Disease
• +۳ مورد دیگر

Professor John Kelly is Professor of Molecular Biology at the London School of Hygiene & Tropical Medicine, leading research on parasitic protozoa causing Chagas disease and African trypanosomiasis. His lab develops genetic tools for functional studies of Trypanosoma cruzi and Trypanosoma brucei, focusing on drug action mechanisms, resistance, and disease pathogenesis. Funded by MRC, DNDi, GSK, and Novartis, his work bridges fundamental science and translational research to develop new treatments for neglected diseases. Key research areas include: Development of genetic tools for trypanosome functional studies Mechanisms of drug action and resistance in Chagas disease Anti-trypanosome drug development pipelines Pathogenesis of Chagas disease using advanced imaging Analysis of Professor Kelly's 15 most recent publications reveals: Persistent investigation of combination therapies for chronic infections Novel approaches to overcoming drug resistance mechanisms Validation of animal models for pathogenesis and drug testing Exploration of molecular targets for trypanocidal compounds His teaching portfolio covers: Molecular parasitology and drug development in LSHTM MSc programs Trypanosome biology lectures at University of Cambridge Supervision of 3 PhD students Professional activities include: Scientific Advisor to Wellcome Trust Visiting Professor at Nagasaki University Member of GSK-Dundee-Wellcome Trust Scientific Advisory Committee Co-organizer of London Molecular Parasitology Club

H.M. Kasuni Akalankaمشاهده پروفایل

پژوهشگر ارشد

• Breast Cancer Research
• Hormonal Therapy
• In Vitro Studies
• +۸ مورد دیگر

H.M. Kasuni Akalanka is a Research Fellow at the Rural Health Research Institute , Charles Sturt University , Australia. She has over 15 years of academic experience, including roles as Senior Lecturer (8 years), Lecturer (7 years), and Head of the Department of Basic Sciences at the University of Sri Jayewardenepura, Sri Lanka. Her work spans multidisciplinary collaborations locally and internationally. Previous Affiliation: School of Medicine and Dentistry, Griffith University (Visiting Research Fellow) Previous Role: Head of Department of Basic Sciences, University of Sri Jayewardenepura Her research interests focus on breast cancer , particularly hormonal and metabolic factors (e.g., testosterone, metformin, statins), cancer biomarkers (e.g., serum sex hormones, lipid profiles, CA 15-3), and public health in low-to-middle-income countries. She explores the use of molecular diagnostics and in vitro models to assess drug efficacy and risk factors. Her recent publications highlight the anti-cancer effects of metformin and atorvastatin on hormone receptor-positive and triple-negative breast cancer subtypes, using in vitro models. Earlier work includes studies on vitamin D status , thyroid profiles , and anthropometric parameters in Sri Lankan populations. Despite extensive contributions to breast cancer research and public health studies, no scientific awards or honors are explicitly mentioned in the provided text. Her academic collaborations and leadership in Sri Lanka's Department of Basic Sciences underscore her impact in clinical biochemistry and epidemiology .

Kenneth Whiteمشاهده پروفایل

استاد

• Iron Homeostasis
• Molecular Mechanisms
• Nanomedicine
• +۳ مورد دیگر

Professor Kenneth White is Head of Research and Knowledge Exchange at London Metropolitan University's School of Human Sciences. With a Chemistry DPhil from Oxford and postdoctoral experience at NIH and Kyoto University, his research bridges molecular biosciences and nanomedicine. Key investigations include iron homeostasis mechanisms, macrophage differentiation in iron recycling, and nanoformulations for anemia treatment using electrohydrodynamic techniques. Additional research explores anti-diabetic phytochemicals and diabetes molecular pathology. Teaching includes Biomedical Diagnostics and Genomic Informatics modules. Awards include JSPS Fellowship and 2019 Big Idea Challenge for 'Soft Iron' nanomedicine. Research funding spans EPSRC, RSC, and Emerald Fund grants. Notable Publications: COVID-19 iron metabolism (Mol Biol Reports 2023), Hepatitis B therapy (Can J Infect Dis 2022) Grants: EPSRC, RSC Research Fund, Emerald Fund

• Epidemiology
• Cancer Risk
• Pharmacoepidemiology
• +۷ مورد دیگر

Rikje Ruiter is a Researcher in the Department of Epidemiology at Erasmus MC, a leading medical research institution in the Netherlands. Her work is deeply embedded in population-based studies, particularly leveraging data from the Rotterdam Study, with a focus on aging, chronic disease, medication use, and cancer risk. Her research interests span epidemiology , cancer risk assessment , pharmacoepidemiology , and geriatric health outcomes . She investigates how long-term medication use, such as antihypertensives and psychotropics, influences disease risk and clinical outcomes in older adults. Her work also addresses multimorbidity, frailty, delirium, and the impact of environmental and genetic factors on health. The trend in her recent publications shows a strong emphasis on validation studies , observational cohort analyses , and systematic reviews with applications in clinical prediction, public health, and personalized medicine. Her research frequently appears in high-impact journals in geriatrics, general practice, and epidemiology. Scientific Contributions: Extensive work on cancer risk and registry-based epidemiology Key contributions to understanding medication effects in aging populations Leadership in studies on delirium, frailty, and multimorbidity in older patients Use of large-scale datasets like the Rotterdam Study for causal and predictive modeling Rikje Ruiter has supervised doctoral research, as indicated by her involvement in a doctoral thesis, and has collaborated widely across national and international networks. While specific grant details are not listed, her research output suggests active participation in funded epidemiological and public health projects. She is not known to lead a standalone lab but is an integral part of collaborative research teams within the Department of Epidemiology.

• Diabetes and Metabolic Disorders
• Biomolecular Research
• Biopolymer Research
• +۳ مورد دیگر

Professor Alexandra Butler is a faculty member at RCSI Bahrain, affiliated with the College of Medicine and the Department of Pathology. Her research focuses on diabetes and metabolic disorders, biomolecular research, and biopolymer research. Research Trends: Her recent publications investigate microRNA dynamics in diabetes, inflammatory markers in polycystic ovary syndrome, hypoglycemia effects, vascular inflammation in coronary disease, and nutritional interventions for metabolic disorders. Scientific Awards: Featured in 'World’s Top 2% Scientists' list published by Stanford University

Liz Coulthardمشاهده پروفایل

استاد

• Cognitive Neurology
• Dementia Research
• Alzheimer's Disease
• +۴ مورد دیگر

Professor Liz Coulthard holds the position of Professor of Cognitive Neurology at the University of Bristol's Bristol Medical School (THS). She specializes in clinical neurology with a focus on dementia and cognitive impairments. Her research integrates clinical practice with epidemiological and neuroimaging approaches. Education: BA (Oxford University), MBBS (University College London), MRCP, PhD (University College London). Research interests center on Alzheimer's disease mechanisms, sleep disturbances in neurodegenerative disorders, and early detection strategies. She leads studies on biomarkers like Fastball neurocognitive assessment and investigates interventions such as liraglutide for Alzheimer's treatment. Her work includes large-scale cohort studies like SleepQuest and the RESTED-AD observational study. Key innovations include remote sleep monitoring protocols and interdisciplinary collaborations with engineers for soft robotics solutions in dementia care. She has contributed to clinical trials evaluating drugs like losartan and liraglutide for neuroprotective effects.

Jed Mortonمشاهده پروفایل

پژوهشگر ارشد

• Epidemiology
• Epidemiological Modelling
• Health Economic Analysis
• +۳ مورد دیگر

Jed Morton is a Research Fellow at the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University, affiliated with the Centre for Medicine Use and Safety . His work focuses on epidemiology, epidemiological modelling, and health economic analysis of diabetes, cardiovascular disease, and kidney disease. He holds a PhD in Epidemiology (Monash University, 2022) and a BSc (Hons) in Science from the University of Melbourne (2018). Dr. Morton contributes to the UN Sustainable Development Goals through research addressing health inequities and chronic disease burden. He holds an external position as part of the Cardiovascular Learning Health Network Data group at Safer Care Victoria (SCV) since October 2022, emphasizing collaboration in healthcare improvement. His research spans topics like diabetes-related end-stage kidney disease projections, socioeconomic disparities in medication access, and cardiovascular disease prevention economics. Notable collaborations include multinational studies on diabetes epidemiology and outcomes. Press coverage highlights his work on cost-effective diabetes drugs and cardiovascular disease prevention strategies. Publications reflect expertise in health economics, registry-based cohort analyses, and disease burden modelling. His work bridges clinical data and policy implications, with a focus on improving healthcare equity and outcomes in chronic disease management.